by Timileyin Ajuwon | Sep 22, 2024 | Florence
As I sit here wanting to get my thoughts out, An image of me stranded in a body of stagnant water comes about. The water is dark and I’m all alone, Holding on to dear life with all its unknown. I’m cold and numb and not sure what to...
by Timileyin Ajuwon | Sep 22, 2024 | My Story to Tell
It’s understandable to feel concerned about how someone might react when you share something personal and sensitive like your diagnosis. However, being open and honest is essential for building trust in any relationship, and if she truly cares for you, she will...
by Timileyin Ajuwon | Sep 5, 2024 | MS ROAD TO A CURE CHARITY CAR SHOW 3
One of York Region’s most acclaimed car shows will return, “bigger and badder” on Saturday, Aug. 31, to display hundreds of amazing four-wheeled vehicles. But it’s two-wheeled vehicles — new powered wheelchairs for their members — that the host group at MS Road to a...
by Timileyin Ajuwon | Sep 5, 2024 | Memorials
It is with profound sadness that the family of Deborah Cross (neé Richardson) announce her passing on August 31st, 2024, at the age of 68, due to complications from Multiple Sclerosis. She will be lovingly remembered by her daughters, Stephanie Cross (Chris Ling) and...
by Timileyin Ajuwon | Aug 28, 2024 | MS TODAY, MS Treatments, Research
From the moment someone is diagnosed with multiple sclerosis, a maze of barriers awaits. But in York Region, such people aren’t alone. Other residents who also have MS, an auto-immune disease affecting the central nervous system, volunteer to help them buy...
by Timileyin Ajuwon | Dec 25, 2023 | MS Medications, MS Meds and your skin conditions, MS TODAY, MS Treatments, VISION
Treatment with Mavenclad (cladribine) over two years significantly improved physical and mental health aspects of quality of life in people with highly active relapsing multiple sclerosis, according to a final analysis of data from a Phase 4 study. Mavenclad is an...
